Susan Perlman

10.6k total citations
152 papers, 5.9k citations indexed

About

Susan Perlman is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Susan Perlman has authored 152 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Cellular and Molecular Neuroscience, 113 papers in Molecular Biology and 73 papers in Neurology. Recurrent topics in Susan Perlman's work include Genetic Neurodegenerative Diseases (127 papers), Mitochondrial Function and Pathology (103 papers) and Neurological disorders and treatments (37 papers). Susan Perlman is often cited by papers focused on Genetic Neurodegenerative Diseases (127 papers), Mitochondrial Function and Pathology (103 papers) and Neurological disorders and treatments (37 papers). Susan Perlman collaborates with scholars based in United States, Australia and United Kingdom. Susan Perlman's co-authors include David R. Lynch, Brent L. Fogel, George Wilmot, Christopher M. Gómez, S. H. Subramony, Thomas Meier, Katherine D. Mathews, Daniel H. Geschwind, Theresa A. Zesiewicz and Richard A. Gatti and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Susan Perlman

143 papers receiving 5.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Susan Perlman 4.4k 4.3k 2.0k 527 507 152 5.9k
Caterina Mariotti 4.4k 1.0× 3.7k 0.9× 1.8k 0.9× 642 1.2× 375 0.7× 158 6.3k
Giuseppe De Michele 3.0k 0.7× 3.9k 0.9× 3.2k 1.6× 1.2k 2.4× 537 1.1× 208 6.8k
Paola Giunti 3.7k 0.8× 3.7k 0.9× 1.7k 0.8× 547 1.0× 405 0.8× 138 5.2k
Manabu Doyu 4.1k 0.9× 3.4k 0.8× 2.5k 1.3× 589 1.1× 576 1.1× 107 6.8k
Thomas D. Bird 4.2k 1.0× 5.9k 1.4× 2.7k 1.4× 1.8k 3.5× 648 1.3× 170 8.6k
Sylvia Boesch 1.8k 0.4× 2.3k 0.5× 1.8k 0.9× 311 0.6× 262 0.5× 127 3.6k
Takeshi Ikeuchi 4.0k 0.9× 2.9k 0.7× 2.4k 1.2× 1.3k 2.5× 353 0.7× 228 7.4k
Suzana Gispert 2.4k 0.5× 2.0k 0.5× 1.9k 0.9× 371 0.7× 341 0.7× 79 4.3k
Miho Murata 1.4k 0.3× 1.6k 0.4× 2.4k 1.2× 509 1.0× 293 0.6× 164 4.8k
Kiyomitsu Oyanagi 1.2k 0.3× 1.1k 0.3× 1.9k 1.0× 812 1.5× 272 0.5× 173 4.2k

Countries citing papers authored by Susan Perlman

Since Specialization
Citations

This map shows the geographic impact of Susan Perlman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Perlman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Perlman more than expected).

Fields of papers citing papers by Susan Perlman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Perlman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Perlman. The network helps show where Susan Perlman may publish in the future.

Co-authorship network of co-authors of Susan Perlman

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Perlman. A scholar is included among the top collaborators of Susan Perlman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Perlman. Susan Perlman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rummey, Christian, Susan Perlman, S. H. Subramony, et al.. (2025). Disease Progression in Children With Friedreich Ataxia: Functional Performance and Other Outcome Assessments in the FACHILD Study. Journal of Child Neurology. 41(3). 321–329.
2.
Perlman, Susan, Mathieu Anheim, Sylvia Boesch, James H. Lewis, & David R. Lynch. (2025). Managing Aminotransferase Elevations in Patients with Friedreich Ataxia Treated with Omaveloxolone: A Review and Expert Opinion on Use Considerations. Neurology and Therapy. 14(4). 1209–1227. 2 indexed citations
3.
4.
Lynch, David R., S. H. Subramony, Kimberly Y. Lin, et al.. (2024). Characterization of Cardiac-Onset Initial Presentation in Friedreich Ataxia. Pediatric Cardiology. 46(2). 379–382. 2 indexed citations
5.
Rummey, Christian, Susan Perlman, S. H. Subramony, Jennifer Farmer, & David R. Lynch. (2024). Evaluating mFARS in pediatric Friedreich's ataxia: Insights from the FACHILD study. Annals of Clinical and Translational Neurology. 11(5). 1290–1300. 5 indexed citations
6.
Bordelon, Yvette, et al.. (2024). Racial Disparities in Time to Huntington Disease Diagnosis in North America. Neurology Clinical Practice. 14(5). e200344–e200344. 3 indexed citations
7.
Lynch, David R., Angie Goldsberry, Christian Rummey, et al.. (2023). Propensity matched comparison of omaveloxolone treatment to Friedreich ataxia natural history data. Annals of Clinical and Translational Neurology. 11(1). 4–16. 24 indexed citations
8.
Lynch, David R., et al.. (2023). Frataxin analysis using triple quadrupole mass spectrometry: application to a large heterogeneous clinical cohort. Journal of Neurology. 271(4). 1844–1849. 2 indexed citations
9.
Garcés, Pilar, Chrystalina A. Antoniades, Anna Sobańska, et al.. (2023). Quantitative Oculomotor Assessment in Hereditary Ataxia: Systematic Review and Consensus by the Ataxia Global Initiative Working Group on Digital-motor Biomarkers. The Cerebellum. 23(3). 896–911. 11 indexed citations
10.
Lynch, David R., Katherine D. Mathews, Susan Perlman, et al.. (2022). Double blind trial of a deuterated form of linoleic acid (RT001) in Friedreich ataxia. Journal of Neurology. 270(3). 1615–1623. 10 indexed citations
11.
Lynch, David R., Melanie Chin, Sylvia Boesch, et al.. (2022). Efficacy of Omaveloxolone in Friedreich's Ataxia: Delayed‐Start Analysis of the MOXIe Extension. Movement Disorders. 38(2). 313–320. 55 indexed citations
12.
Rummey, Christian, Louise A. Corben, Martin B. Delatycki, et al.. (2022). Natural History of Friedreich Ataxia. Neurology. 99(14). e1499–e1510. 33 indexed citations
13.
Rummey, Christian, John M. Flynn, Louise A. Corben, et al.. (2021). Scoliosis in Friedreich's ataxia: longitudinal characterization in a large heterogeneous cohort. Annals of Clinical and Translational Neurology. 8(6). 1239–1250. 17 indexed citations
14.
Wong, Darice Y., Claudio M. de Gusmão, May Sanyoura, et al.. (2020). Prevalence of RFC1 -mediated spinocerebellar ataxia in a North American ataxia cohort. Neurology Genetics. 6(3). e440–e440. 32 indexed citations
15.
Lynch, David R., Melanie Chin, Martin B. Delatycki, et al.. (2020). Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study). Annals of Neurology. 89(2). 212–225. 177 indexed citations
16.
Wong, Darice Y., Claudio M. de Gusmão, May Sanyoura, et al.. (2020). Prevalence of RFC1-Mediated Spinocerebellar Ataxia in a North American Ataxia Cohort. Annals of Neurology. 88. 3 indexed citations
17.
Schneider, Andrea, Dragana Protić, Jun Yi Wang, et al.. (2020). <p>Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer’s Disease</p>. Clinical Interventions in Aging. Volume 15. 285–292. 6 indexed citations
18.
Moscovich, Mariana, Michael S. Okun, Christopher G. Favilla, et al.. (2014). Clinical Evaluation of Eye Movements in Spinocerebellar Ataxias. Journal of Neuro-Ophthalmology. 35(1). 16–21. 46 indexed citations
19.
Zesiewicz, Theresa A., Seok Hun Kim, Kelly L. Sullivan, et al.. (2014). Treatment of Neurodegenerative Ataxias With Intravenous Immune Globulin. Journal of Neurology Research. 4(4). 97–100. 1 indexed citations
20.
Child, John, et al.. (1986). Cardiac involvement in Friedreich's ataxia: A clinical study of 75 patients. Journal of the American College of Cardiology. 7(6). 1370–1378. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caterina Mariotti Breakdown of academic impact, for papers by Giuseppe De Michele Breakdown of academic impact, for papers by Paola Giunti Breakdown of academic impact, for papers by Manabu Doyu Breakdown of academic impact, for papers by Thomas D. Bird Breakdown of academic impact, for papers by Sylvia Boesch Breakdown of academic impact, for papers by Takeshi Ikeuchi Breakdown of academic impact, for papers by Suzana Gispert Breakdown of academic impact, for papers by Miho Murata Breakdown of academic impact, for papers by Kiyomitsu Oyanagi
Rankless by CCL
2026